Levmentin

Amoxicillin and Clavulanic Acid, the active ingredient in Levmentin, is a penicillin/β‑lactamase inhibitor combination presented as an injectable solution for intravenous use. It treats bacterial infections such as respiratory, urinary, intra‑abdominal, and skin/soft‑tissue infections in adult patients.

GNH USA supplies Levmentin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for injectable medicines. Clients benefit from on‑time delivery, regulatory support and comprehensive after‑sales service.

Levmentin, a penicillin/β‑lactamase inhibitor combination, is employed to manage bacterial infections affecting various organ systems.

- Respiratory tract infections: effective against common pathogens causing pneumonia, bronchitis and sinusitis. - Urinary tract infections: eradicates susceptible Gram‑negative and Gram‑positive bacteria causing cystitis and pyelonephritis. - Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic organisms in peritonitis and postoperative infections. - Skin and soft tissue infections: treats cellulitis, abscesses and wound infections caused by susceptible bacteria.

Adverse reactions to Levmentin may vary in frequency and severity.

Common Side Effects: - Diarrhea: mild to moderate watery stools. - Nausea: feeling of queasiness. - Rash: erythematous skin eruption.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Clostridioides difficile‑associated diarrhea: severe colitis. - Stevens‑Johnson syndrome: extensive skin detachment.

Before using Levmentin, consider the following precautions to ensure safe administration. - Renal impairment: dose may need adjustment and renal function should be monitored. - Hepatic dysfunction: monitor liver enzymes during therapy. - History of penicillin allergy: avoid use in patients with known hypersensitivity. - Concomitant anticoagulant therapy: monitor INR or PT for increased bleeding risk. - Use in pregnancy and lactation: only if benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levmentin can interact with other medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Probenecid: reduces renal excretion of amoxicillin, increasing plasma levels. - Methotrexate: may enhance methotrexate toxicity. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Oral contraceptives: may reduce efficacy, leading to breakthrough bleeding.

Moderate Interactions (Monitor Closely): - Allopurinol: increased risk of skin rash. - Ciprofloxacin: possible antagonism reducing antibacterial activity. - Clarithromycin: may increase liver enzyme elevations.